According to Redhill Biopharma's latest financial reports the company's current earnings (TTM) are S$15.07 M. In 2022 the company made an earning of -S$93.36 M an increase over its 2021 earnings that were of -S$0.13 B.The earnings displayed on this page is the company's Pretax Income.